Skip to main content
. 2016 Jan 18;7(7):8155–8171. doi: 10.18632/oncotarget.6943

Figure 5. Effect of E2 on tumor angiogenesis and intratumoral TAM densities in in vivo preclinical models of ovarian cancer.

Figure 5

A. Immunohistochemical analysis showed in both experimental models a significant higher MVD (Microvessel Density) in E2-treated (***P<0.001, n=8 tumors/group) compared to Ovx females. Representative images for CD31 immunostaining of tumors from Ovx and Ovx+E2 mice (magnification 40x). B. Representative pictures for immunohistochemical staining of Arginase I-positive macrophages (Arg1) in HEY xenograft from E2-treated mice. Magnification 20x and 40x. Results obtained showed a significant increase of the ratio Arg1/CD11b in E2-treated compared to untreated Ovx mice (**P<0.01, n=8 tumors/group).